Coursera Spring Sale
40% Off Coursera Plus Annual!
Grab it
In this 26-minute video, Dr. Paul Richardson from Dana-Farber Cancer Institute offers a clinical perspective on emerging treatment approaches for patients with relapsed/refractory multiple myeloma. Gain insights into innovative therapies that show promise for improving outcomes in this challenging disease setting. Explore the evolving landscape of multiple myeloma management, including new drug combinations, immunotherapies, and targeted approaches that are reshaping treatment paradigms for patients who have experienced disease progression after initial therapy.
